Yaqin Li

Yaqin Li

Auto-generated profile, based on publicly available information

Yaqin Li

School of Acu-Mox and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2023 in Frontiers in Neurology
Verified
Journal Article
Open access
ZYZihan Yin
Zihan Yin
YLYaqin Li
Yaqin Li
CJCheng Jiang
Cheng Jiang
MXManze Xia
Manze Xia
ZCZhenghong Chen
Zhenghong Chen
FLFan-rong Liang
Fan-rong Liang
Background: There is insufficient evidence to support the use of acupuncture for mild cognitive impairment (MCI), and there is no consensus on its efficacy. This review aimed to determine the acupuncture effect in patients with MCI.Methods: Relevant and potentially eligible randomized controlled trials (RCTs) of acupuncture for MCI were obtained from four Chinese databases, four English databases, and additional resources up to 1 August 2022. The primary outcome was the improvement in overall cognitive function (OCF). Secondary outcomes were improved memory function (MF) and activities of daily living (ADLs). The revised Cochrane collaboration risk of bias (ROB) assessment tool (ROB 2.0) was applied to evaluate their methodological quality. The Review Manager software v 5.4 was used for analyses. Trial sequential analysis (TSA) 0.9.5.10 β software was used to estimate the required sample size and test the reliability of the pooled outcome. The quality of evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) tool.Results: This meta-analysis included 11 RCTs with a total of 602 patients. The methodological quality of all trials was moderate. Low-quality evidence showed that acupuncture significantly improved OCF (Mini-Mental State Examination (MMSE): mean difference (MD) = 1.22, 95% confidence interval (CI): 0.78–1.66; the Montreal Cognitive Assessment Scale (MoCA): MD = 1.22, 95% CI: 0.47–1.97). In subgroup analyses, it was revealed that acupuncture significantly increased OCF in patients with MCI when compared to conventional medicine (CM) and sham acupuncture (SA). TSA's findings indicated that the evidence of improving OCF with acupuncture for patients with MCI was conclusive. Meanwhile, there is no statistical difference in the improvement of MF and ADL between acupuncture and CM. TSA showed that the evidence of improving MF and ADL for patients who had MCI and received acupuncture was inconclusive. The shreds of evidence of improving MF and ADL were ranked from low to critically low.Conclusion: Acupuncture appears to be an effective clinical application method for improving OCF in patients with MCI. However, due to low-quality evidence, more relevant and high-quality research is needed in this field.Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021291284, PROSPERO, No. CRD42021291284.

11 November 2014 in Respiratory Care
Verified
Journal Article
Open access
YLYanming Lu
Yanming Lu
LXLingyun Xu
Lingyun Xu
MXMin Xia
Min Xia
YLYaqin Li
Yaqin Li
LCLanfang Cao
Lanfang Cao
BACKGROUND: Subcutaneous immunotherapy (SCIT) is widely used in the management of allergic diseases such as allergic asthma. We aimed to conduct a systematic review and meta-analysis to evaluate the efficacy and safety of SCIT in mite-sensitized subjects with asthma. METHODS: Literature from January 1990 to February 2013 on the efficacy and safety of SCIT for mite-sensitized asthma patients was searched in electronic databases, including the Cochrane Library, MEDLINE, Embase, PubMed, China Knowledge Resource Integrated Database, Wanfang, and Vendor Information Pages. Data were extracted from randomized controlled trials (RCTs) according to the selection criteria by 2 investigators independently. The quality of included trials was evaluated according to the Jadad scale standard. RESULTS: A total of 796 subjects from 19 different RCTs were included in this analysis. SCIT significantly reduced the asthma symptom scores (standardized mean difference of −0.94, 95% CI −1.58 to −0.29, P = .004) and the asthma medication scores (standardized mean difference of −1.06, 95% CI −1.70 to −0.42, P = .001) compared with the control group. However, there were no significant differences between subjects receiving SCIT and the control group in lung function (peak expiratory flow, percent-of-predicted FEV 1 , percent-of-predicted FVC) and specific antibody (allergen-specific immunoglobulin E) levels of blood serum ( P > .05). In the studies containing data on safety, the incidences of systemic and local adverse reactions were 9.1% (8/88) and 17.2% (23/134), respectively, in subjects treated with SCIT, and no severe adverse events were reported. CONCLUSIONS: Our results suggest that SCIT is helpful in alleviating symptoms and reducing medication used in mite-sensitive asthma subjects, but with no improvement in lung function. The safety of SCIT is acceptable.

30 August 2022 in Journal of Alloys and Compounds
Verified
Journal Article
Closed access
YLYaqin Li
Yaqin Li
YZYang-Huan Zhang
Yang-Huan Zhang
HSHongwei Shang
Hongwei Shang
JGJinliang Gao
Jinliang Gao
WZWei Zhang
Wei Zhang
Lin JuLin Ju
Lin Ju

15 April 2022 in European Journal of Integrative Medicine
Verified
Journal Article
Open access
ZYZihan Yin
Zihan Yin
YLYaqin Li
Yaqin Li
XZXinyue Zhang
Xinyue Zhang
MXManze Xia
Manze Xia
ZCZhenghong Chen
Zhenghong Chen
FLFan-rong Liang
Fan-rong Liang

23 June 2021 in Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
WZWeihong Zhao
Weihong Zhao
YLYaqin Li
Yaqin Li
HZHonglei Zhang
Honglei Zhang
YLYatao Liu
Yatao Liu
Endometriosis is a common gynaecologic disorder; it occurs most commonly in the pelvic cavity, less in extrapelvic regions (Benagiano et al. 2014). Thoracic or mediastinal endometriosis is a rare f...